Rationale and Design of the Cessation Of Pharmacotherapy In Recovered Chemotherapy-induced cardioToxicity (COP-RCT): A Pilot Study

- Yu, Christopher, Negishi, Tomoko, Pathan, Faraz, Sverdlov, Aaron, Thomas, Liza, Shirazi, Mitra, Koo, Chieh Yang, Tan, Li Ling, Miyazaki, Sakiko, Negishi, Kazuaki

Consensus statement on the current pharmacological prevention and management of heart failure

- Sindone, Andrew P., De Pasquale, Carmine, Amerena, John, Burdeniuk, Christine, Chan, Alicia, Coats, Andrew, Hare, David L., Macdonald, Peter, Sverdlov, Aaron, Atherton, John J.

Prevalence and survival associated with pulmonary hypertension after mitral valve replacement: National echocardiography database of Australia study

- Collins, Nicholas, Sugito, Stuart, Davies, Allan, Boyle, Andrew, Sverdlov, Aaron, Attia, John, Stewart, Simon, Playford, David, Strange, Geoff

Effects of lockdown on acute coronary syndrome incidence in an area without community transmission of COVID-19

- Ferreira, David, Graffen, Simon, Watkins, Brendan, Peters, Bridie, Lim, Geok Jim, Kamalanathan, Harish, Leitch, James, Sverdlov, Aaron, Collins, Nicholas, Boyle, Andrew, Davies, Allan

Galectin-3 is associated with Stage B metabolic heart disease and pulmonary hypertension in young obese patients

- Gopal, Deepa M., Ayalon, Nir, Wang, Yi-Chih, Siwik, Deborah, Sverdlov, Aaron, Donohue, Courtney, Perez, Alejandro, Downing, Jill, Apovian, Caroline, Silva, Vanessa, Panagia, Marcello, Kolachalama, Vijaya, Ho, Jennifer E., Liang, Chang-seng, Gokce, Noyan, Colucci, Wwilson S.